F-16505

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameF-16505

Drug Alias NameF-16505

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPeroxisome proliferator-activated receptor α modulatorsPeroxisome proliferator-activated receptor γ modulatorsHDL-cholesterol inhibitors

TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor αHDL-cholesterol

Therapy Area/IndicationsLipid Metabolism Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPierre Fabre Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPierre Fabre Ltd

Active IndicationsN/A

Inactive IndicationsLipid Metabolism Disorders

Other Information

ATC CodeN/A